Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-  in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain

Transgenic Mouse ◽

Mouse Brain ◽

Emission Tomography ◽

Positron Emission Tomography Tracer ◽

Pittsburgh Compound B ◽

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(08)79054-9 ◽

2008 ◽

Vol 2008 ◽

pp. 7-8

Author(s):

T.J. Grabowski

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose Positron Emission

Cognitive Reserve ◽

Emission Tomography ◽

Fluorodeoxyglucose Positron Emission Tomography ◽

Pittsburgh Compound B ◽

Positron Emission ◽

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp-2012-302548 ◽

2012 ◽

Vol 83 (9) ◽

pp. 923-926 ◽

Cited By ~ 60

Author(s):

David A Wolk ◽

Zheng Zhang ◽

Sanaa Boudhar ◽

Christopher M Clark ◽

Michael J Pontecorvo ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Amyloid Imaging ◽

Emission Tomography ◽

Pittsburgh Compound B ◽

Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2017.12.016 ◽

2018 ◽

Vol 48 ◽

pp. 3-9 ◽

Cited By ~ 15

Author(s):

Jennifer L. Whitwell ◽

J. Eric Ahlskog ◽

Nirubol Tosakulwong ◽

Matthew L. Senjem ◽

Anthony J. Spychalla ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Progressive Supranuclear Palsy ◽

Emission Tomography ◽

Pittsburgh Compound B ◽

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

Annals of Neurology ◽

10.1002/ana.21212 ◽

2008 ◽

Vol 63 (1) ◽

pp. 112-118 ◽

Cited By ~ 136

Author(s):

Nina M. Kemppainen ◽

Sargo Aalto ◽

Mira Karrasch ◽

Kjell Någren ◽

Nina Savisto ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose Positron Emission

Cognitive Reserve ◽

Emission Tomography ◽

Fluorodeoxyglucose Positron Emission Tomography ◽

Pittsburgh Compound B ◽

Positron Emission ◽

P1-300: The relationship between cerebral spinal fluid (CSF) biomarkers and Pittsburgh Compound B (PiB) positron emission tomography (PET) in predicting Alzheimer's disease (AD)

10.1016/j.jalz.2011.05.579 ◽

2011 ◽

Vol 7 ◽

pp. S206-S206 ◽

Cited By ~ 1

Author(s):

Leah Burns ◽

Robert Berman ◽

Zhenchao Guo ◽

Holly Soares ◽

Stephen Kaplita ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cerebral Spinal Fluid ◽

Spinal Fluid ◽

Emission Tomography ◽

Csf Biomarkers ◽

Pittsburgh Compound B ◽

Positron Emission ◽

The Relationship

O4-10-05: DECREASED SERUM LEVELS OF ALBUMIN-TAU COMPLEXES ARE A VALUABLE BIOMARKER FOR DISTINGUISHING BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA FROM ALZHEIMER'S DISEASE WITH PITTSBURGH COMPOUND B-POSITRON EMISSION TOMOGRAPHY CONFIRMATION

10.1016/j.jalz.2014.04.443 ◽

2014 ◽

Vol 10 ◽

pp. P272-P272

Author(s):

Keiichi Yamamoto ◽

Hiroyuki Shimada ◽

Suzuka Ataka ◽

Yoshihiro Yamakawa ◽

Takami Miki

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Frontotemporal Dementia ◽

Serum Levels ◽

Emission Tomography ◽

Pittsburgh Compound B ◽

Behavioral Variant Frontotemporal Dementia ◽

Characterization of tau positron emission tomography tracer [18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias

10.1016/j.jalz.2016.01.003 ◽

2016 ◽

Vol 12 (11) ◽

pp. 1116-1124 ◽

Cited By ~ 115

Author(s):

Kerstin Sander ◽

Tammaryn Lashley ◽

Priya Gami ◽

Thibault Gendron ◽

Mark F. Lythgoe ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Emission Tomography ◽

Positron Emission Tomography Tracer ◽

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease

Brain ◽

10.1093/brain/awq349 ◽

2010 ◽

Vol 134 (1) ◽

pp. 301-317 ◽

Cited By ~ 87

Author(s):

Ahmadul Kadir ◽

Amelia Marutle ◽

Daniel Gonzalez ◽

Michael Schöll ◽

Ove Almkvist ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Molecular Pathology ◽

Positron Emission Tomography Imaging ◽

Emission Tomography ◽

Clinical Progression ◽

Pittsburgh Compound B ◽

Tomography Imaging ◽

P1-131: Suspected Alzheimer's disease with negative pittsburgh compound-B positron emission tomography

10.1016/j.jalz.2009.04.136 ◽

2009 ◽

Vol 5 (4S_Part_7) ◽

pp. P215-P215

Author(s):

Jae-Hong Lee ◽

Miseon Kwon ◽

Ji-Young Kim

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Emission Tomography ◽

Pittsburgh Compound B ◽

Positron Emission Tomography with Pittsburgh Compound B in Diagnosis of Early Stage Alzheimer’s Disease

Cell Biochemistry and Biophysics ◽

10.1007/s12013-010-9111-2 ◽

2010 ◽

Vol 59 (1) ◽

pp. 57-62 ◽

Cited By ~ 1

Author(s):

Jianjun Jia ◽

Binbin Sun ◽

Zhe Guo ◽

Jinming Zhang ◽

Jiahe Tian ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Early Stage ◽

Emission Tomography ◽

Pittsburgh Compound B ◽